Lori Kobayashi’s diverse experience as a scientist and project manager uniquely position her to lead a research program whose goal is to identify biomarkers for early diagnosis of neurodegenerative diseases and develop diagnostic assays to monitor drug therapy. As a project manager for Valted Seq—a company using single-cell sequencing data to advance breakthrough precision therapeutics for neurodegenerative diseases—Kobayashi is using big data to break new ground.
Where has your journey as a scientist taken you?
I have a benchwork background, working at different diagnostic companies as a scientist and transitioning to project management over the last five years. After graduate school, I started working in a laboratory at the National Cancer Institute investigating different ways to identify natural compounds that may fight cancer, as well as screening proteins. One of those projects evolved to working with a company that was using some of the proteins that we were looking at ...
